Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.73 by 6.85 percent. This is a 21.88 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $1.649 billion which beat the analyst consensus estimate of $1.596 billion by 3.33 percent. This is a 16.95 percent increase over sales of $1.410 billion the same period last year.